Comparison of pleural <scp>N</scp>‐terminal pro‐<scp>B</scp>‐type natriuretic peptide, midregion pro‐atrial natriuretic peptide and mid‐region pro‐adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure

Abstract

MR-proANP is as valuable a diagnostic tool as NT-proBNP for diagnosing or excluding HF as the cause of pleural effusion.